Cite
[Ceftriaxone as a single agent in empirical therapy of infection in patients with hematologic disorders. Hanshin Infection Study Group].
MLA
Kuyama, J., et al. “[Ceftriaxone as a Single Agent in Empirical Therapy of Infection in Patients with Hematologic Disorders. Hanshin Infection Study Group].” The Japanese Journal of Antibiotics, vol. 42, no. 4, Apr. 1989, pp. 930–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2671427&authtype=sso&custid=ns315887.
APA
Kuyama, J., Yonezawa, T., Kageyama, T., Ohyabu, H., Kitani, T., Taniguchi, N., Masaoka, T., Shibata, H., Yasunaga, K., Fujitake, H., & et. al. (1989). [Ceftriaxone as a single agent in empirical therapy of infection in patients with hematologic disorders. Hanshin Infection Study Group]. The Japanese Journal of Antibiotics, 42(4), 930–937.
Chicago
Kuyama, J, T Yonezawa, T Kageyama, H Ohyabu, T Kitani, N Taniguchi, T Masaoka, et al. 1989. “[Ceftriaxone as a Single Agent in Empirical Therapy of Infection in Patients with Hematologic Disorders. Hanshin Infection Study Group].” The Japanese Journal of Antibiotics 42 (4): 930–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2671427&authtype=sso&custid=ns315887.